Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study

2016 ◽  
Vol 48 (2) ◽  
pp. 639-642 ◽  
Author(s):  
J.A. García-Bello ◽  
E.G. Romo-Del Río ◽  
E. Mendoza-Gómez ◽  
P.A. Camarena-Arias ◽  
M. Santos-Caballero
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Comparative Study ◽  
Immunosuppressive Therapy ◽  
Cardiovascular Risk Factor ◽  
Risk Factor Prevalence

Trends in cardiovascular risk factor prevalence among Lithuanian middle-aged adults between 2009 and 2018

2020 ◽  
Vol 299 ◽  
pp. 9-14
Author(s):  
Aleksandras Laucevičius ◽  
Egidija Rinkūnienė ◽  
Žaneta Petrulionienė ◽  
Ligita Ryliškytė ◽  
Agnė Jucevičienė ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Middle Aged ◽  
Risk Factor Prevalence ◽  
Middle Aged Adults

RACIAL AND ETHNIC DIFFERENCES IN CARDIOVASCULAR RISK FACTOR PREVALENCE AND AWARENESS

2014 ◽  
Vol 30 (10) ◽  
pp. S305
Author(s):  
E. Coomes ◽  
L.R. Finken ◽  
K.K. Quadros ◽  
R.R. Bajaj ◽  
W. Sharieff ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Ethnic Differences ◽  
Cardiovascular Risk Factor ◽  
Racial And Ethnic Differences ◽  
Risk Factor Prevalence

scholarly journals Linking big data for cardiovascular health surveillance – opportunities and challenges using the CANHEART cohort

2018 ◽  
Vol 3 (4) ◽  
Author(s):  
Anna Chu ◽  
Deirdre Hennessy ◽  
Sharon Johnston ◽  
Jacob Udell ◽  
Dennis Ko ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Big Data ◽  
Risk Factor ◽  
Cardiovascular Risk ◽  
Population Health ◽  
Cardiovascular Risk Factor ◽  
Cardiovascular Health ◽  
Population Based ◽  
Health Surveillance ◽  
Risk Factor Prevalence

IntroductionOur increasing ability to link large population-based health administrative datasets to create ‘big data’ cohorts offers unique opportunities to conduct health and health services surveillance at lower costs than traditional methods using surveys or primary data collection. However, comparability of findings from big data with traditional methods is unknown. Objectives and ApproachIn the CArdiovascular HEalth in Ambulatory Care Research Team (CANHEART) ‘big data’ initiative, we linked 19 population-based health databases to obtain baseline and 5-year follow-up health information on a cohort of 9.8 million adult residents of Ontario, Canada as of January 2008. We compared cardiovascular risk factor prevalence with results from 3500 participants in the 2007-09 Canadian Health Measures Survey (CHMS), a traditional population health surveillance survey. Additionally, we determined cardiovascular preventative care use and clinical event rates by sex and age. Planned linkages to new data sources will enable continued cohort surveillance of population health-related and care indicators. ResultsCholesterol and glucose levels determined from the CANHEART cohort were comparable to the CHMS, whereas blood pressure values and obesity rates were substantially higher. Overall, receipt of cardiovascular preventive care in the CANHEART cohort was high, with 85.7% of males and 91.8% of females having blood pressure assessments, and 67.8% of males and 79.4% of females having weight assessments. Cholesterol and diabetes screening rates among those recommended for screening were over 75%. Incidence of myocardial infarction, stroke or cardiovascular death was 51% higher among males than females (3.8 and 2.5 events per 1000 person-years, respectively). Challenges encountered in analyzing data included treatment of repeated and time-varying measures, selection of valid diagnostic and physician billing codes, changing coding practices and handling of missing and outlying data. Conclusion/ImplicationsComparability of cardiovascular risk factor prevalence using linked administrative data with survey methods varies by indicator. Selection biases amongst survey participants and different measurement methods could explain discrepancies. The added ability to examine health care indicators longitudinally and by subgroup supports use of linked population-based data to enhance health surveillance.

Trends in cardiovascular risk factor prevalence in 50-55-year-old Lithuanian men and women

2021 ◽  
Vol 331 ◽  
pp. e152-e153
Author(s):  
E. Rinkuniene ◽  
V. Dzenkeviciute ◽  
Z. Petrulioniene ◽  
E. Majauskienė ◽  
R. Puronaitė ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Men And Women ◽  
Risk Factor Prevalence

THE HONG KONG CARDIOVASCULAR RISK FACTOR PREVALENCE SURVEY COHORT - RESULTS AT 7 YEARS

2004 ◽  
Vol 22 (Suppl. 2) ◽  
pp. S268-S269 ◽  
Author(s):  
B. M.Y. Cheung ◽  
T. H. Lam ◽  
K. S.L. Lam ◽  
S. C.F. Tarn ◽  
N. M.S. Wat ◽  
...  
Keyword(s):  
Risk Factor ◽  
Hong Kong ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Prevalence Survey ◽  
Risk Factor Prevalence

Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain

2007 ◽  
Vol 14 (5) ◽  
pp. 653-659 ◽  
Author(s):  
Maria Grau ◽  
Isaac Subirana ◽  
Roberto Elosua ◽  
Pascual Solanas ◽  
Rafel Ramos ◽  
...  
Keyword(s):  
Risk Factor ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factor ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Lipoprotein Cholesterol ◽  
Lipid Lowering ◽  
Low Density ◽  
Low Density Lipoprotein Cholesterol ◽  
Risk Factor Prevalence

Background High prevalence of cardiovascular risk factors has been observed in Spain along with low incidence of acute myocardial infarction. Our objective was to determine the trends of cardiovascular risk factor prevalence between 1995 and 2005 in the 35-74-year-old population of Gerona, Spain. Design Comparison of cross-sectional studies were conducted in random population samples in 1995, 2000, and 2005 at Gerona, Spain. Methods An electrocardiogram was obtained, along with standardized measurements of body mass index, lipid profile, systolic and diastolic blood pressure, glycaemia, energy expenditure in physical activity, smoking, use of lipid-lowering and antihypertensive medications, and cardiovascular risk. Prevalence of diabetes, hypertension, and obesity was calculated and standardized for age. Results A total of 7571 individuals (52.0% women) were included (response rate 72%). Low-density lipoprotein cholesterol > 3.4 mmol/l (130 mg/dl) (49.7%) and hypertension (39.1%) were the most prevalent cardiovascular risk factors. In 1995, 2000 and 2005, low-density lipoprotein cholesterol decreased in both men and women: 4.05-3.913.55 mmol/l (156-151-137 mg/dl) and 3.84-3.81-3.40 mmol/l (148-147-131 mg/dl), respectively. Increases were observed in lipid-lowering drug use (5.7-6.3-9.6% in men and 4.0-5.8-8.0% in women), controlled hypertension (14.8-35.4-37.7% in men and 21.3-36.9-45.0% in women); (all P-trends < 0.01), and obesity (greatest for men: 17.5-26.0-22.7%, P-trends = 0.020). Prevalence of myocardial infarction or possibly abnormal Q waves in electrocardiogram also increased significantly (3.9-4.7-6.4%, P-trends = 0.018). Conclusions The cardiovascular risk factor prevalence change in Gerona was marked in this decade by a shift of total cholesterol and low-density lipoprotein cholesterol distributions to the left, independent of the increase in lipid-lowering drug use, and better hypertension control with increased use of antihypertensive drugs. Eur J Cardiovasc Prev Rehabil 14:653-659 © 2007 The European Society of Cardiology

Sign in / Sign up

Export Citation Format

Share Document